BRTX vs CB · rev $401.0K vs P/E 14, rev $59.40B
BioRestorative Therapies Inc (BRTX) versus Chubb Ltd (CB) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
BRTX currently screens at market cap $10.2M. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Not investment advice. Open the BRTX and CB stock pages for the full models.
Not investment advice.